NCT06090201View on ClinicalTrials.gov

Severe Congenital Hemostatic Defects, Cerebral MIcrobleeds and COGnition

Not yet recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

November 30, 2023

Primary Completion Date

May 31, 2026

Study Completion Date

August 31, 2026

Conditions
Cerebral Microbleeds, Congenital Haemophilia, Congenital Von Willebrand Disease
Interventions
OTHER

3-Tesla brain MRI and a comprehensive neuropsychological assessment

Patients with a moderate to severe form of congenital haemophilia A or B or a severe form of von Willebrand disease will be consecutively recruited in the study during a routine follow-up visit at the Haemostasis and Transfusion Department of the Lille University Hospital.

All Listed Sponsors
lead

University Hospital, Lille

OTHER

NCT06090201 - Severe Congenital Hemostatic Defects, Cerebral MIcrobleeds and COGnition | Biotech Hunter | Biotech Hunter